These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases]. Ryss ES; Fishzon-Ryss IuI Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263 [No Abstract] [Full Text] [Related]
5. Role of prokinetic drugs for treatment of postoperative ileus in the horse. Dart AJ; Hodgson DR Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763 [TBL] [Abstract][Full Text] [Related]
6. Cisapride: its use in children. Newell SJ Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312 [No Abstract] [Full Text] [Related]
7. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
8. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
9. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Megens AA; Awouters FH; Niemegeers CJ Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352 [TBL] [Abstract][Full Text] [Related]
10. Prokinetic drugs: metoclopramide and cisapride. Dowling PM Can Vet J; 1995 Feb; 36(2):115-6. PubMed ID: 7728729 [No Abstract] [Full Text] [Related]
11. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
12. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. Yoshida N; Ito T; Karasawa T; Itoh Z J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519 [TBL] [Abstract][Full Text] [Related]
14. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
15. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. Gullikson GW; Loeffler RF; Viriña MA J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288 [TBL] [Abstract][Full Text] [Related]
16. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789 [TBL] [Abstract][Full Text] [Related]
17. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
18. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. McCallum RW Am J Gastroenterol; 1991 Feb; 86(2):135-49. PubMed ID: 1992624 [No Abstract] [Full Text] [Related]
19. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride]. Van Nueten JM; Schuurkes JA J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298 [TBL] [Abstract][Full Text] [Related]
20. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats. Lee HT; Lee YJ; Chung SJ; Shim CK Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]